CSL BEHRING LLC for CSL BEHRING LLC
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Follow-up legislation to tax reform
Foreign entity interest: CSL Limited, identified on form LD-1, has an interest in the activities of its U.S. subsidiary CSL Behring on all issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PATRICK COLLINS | — |
| JULIA GRANT | — |
Trade (domestic/foreign) TRD
Renewal of the Office of Foreign Assets Control license for toll manufacturing of therapies for international distribution
Foreign entity interest: CSL Limited, identified on form LD-1, has an interest in the activities of its U.S. subsidiary CSL Behring on all issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PATRICK COLLINS | — |
| JULIA GRANT | — |
Health Issues HCR
H.R. 3178--Medicare Part B Improvement Act of 2017--Home infusion provision for DME administered drugs incorporated within the budget deal Preserving Access to Orphan Therapies Act--Exploration of fine tuning orphan drug exclusion from the annual pharmaceutical fee Educating congressional staff specific to the value of drug therapies (drug pricing, value, access to therapies, etc.)
Foreign entity interest: CSL Limited, identified on form LD-1, has an interest in the activities of its U.S. subsidiary CSL Behring on all issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PATRICK COLLINS | — |
| JULIA GRANT | — |
| DENNIS JACKMAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.